Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.

ABSTRACT:

Background & aims

Patients affected by hepatocellular carcinoma (HCC) represent a vulnerable population during the COVID-19 pandemic and may suffer from altered allocation of healthcare resources. The aim of this study was to determine the impact of the COVID-19 pandemic on the management of patients with HCC within 6 referral centres in the metropolitan area of Paris, France.

Methods

We performed a multicentre, retrospective, cross-sectional study on the management of patients with HCC during the first 6 weeks of the COVID-19 pandemic (exposed group), compared with the same period in 2019 (unexposed group). We included all patients discussed in multidisciplinary tumour board (MTB) meetings and/or patients undergoing a radiological or surgical programmed procedure during the

SUBMITTER: Amaddeo G 

PROVIDER: S-EPMC7604130 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature